Adicet Bio, Inc.
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
ACET | US
Overview
Corporate Details
- ISIN(s):
- US0070021086
- LEI:
- Country:
- United States of America
- Address:
- 131 DARTMOUTH STREET, 2116 BOSTON
- Website:
- https://www.adicetbio.com/
- Sector:
- Manufacturing
Description
Adicet Bio, Inc. is a clinical-stage biotechnology company focused on the discovery and development of allogeneic gamma delta T cell therapies. The company's core mission is to create 'off-the-shelf' treatments for patients with cancer and autoimmune diseases. By engineering gamma delta T cells, Adicet aims to provide readily available and potent immunotherapies. Its proprietary platform is designed to leverage the unique characteristics of these cells, which possess both innate and adaptive immune properties, to develop potentially first-in-class and best-in-class therapeutic candidates that can effectively target and eliminate diseased cells.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Adicet Bio, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Adicet Bio, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Adicet Bio, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
